Accutane (Isotretinoin) Delayed-Onset Side Effects: What Appears Weeks or Months After Treatment
At a glance
- Drug / oral isotretinoin (Accutane, Absorica, Absorica LD, generics)
- Approved use / severe recalcitrant nodular acne in non-pregnant patients 12 and older [1]
- Effects the labels say may persist / hair loss (persisted in some cases), decreased night vision [1][2]; sexual dysfunction (Absorica and Absorica LD label) [1]
- Depression pattern / subsided on stopping and recurred on restarting in some patients [1][2]
- Reversibility / most reactions in clinical trials were reversible on stopping, but some persisted (Accutane-format label) [2]
- Post-treatment intervals / blood donation 1 month, breastfeeding 8 days, skin resurfacing 6 months, repeat course 8 weeks to 2 months [1][2]
What the labels say may persist after the last dose
Hair loss. Alopecia is listed among skin reactions as alopecia 'which in some cases persisted' [1][2].
Decreased night vision. The ocular list includes 'decreased night vision which may persist' [1][2].
Sexual function. The Absorica and Absorica LD label lists abnormal menses and 'sexual dysfunction that may continue after discontinuation of treatment,' including erectile dysfunction, decreased libido, decreased vaginal lubrication, and vaginal dryness [1]. The Accutane label lists abnormal menses in that section without the continuing-dysfunction wording [2].
Depression. Both labels state that of the patients reporting depression, some reported that the depression subsided with discontinuation of treatment and recurred with reinstitution of treatment [1][2].
Post-treatment intervals the labels define
- Blood donation: the Absorica and Absorica LD label says patients should not donate blood during treatment or for 1 month afterward, because the blood might be given to a pregnant patient whose fetus must not be exposed to isotretinoin [1].
- Breastfeeding: not recommended during treatment and for at least 8 days after the last dose [1].
- Skin procedures: the labels advise avoiding waxing and skin resurfacing during treatment and for at least 6 months afterward because of scarring [1][2].
- Second course: the Accutane label says a repeat course should not begin until at least 8 weeks after the first, and the Absorica label puts the waiting period at 2 months [1][2].
Frequently asked questions
What side effects can persist after stopping isotretinoin?
Both labels list hair loss that persisted in some cases and decreased night vision that may persist [1][2]. The Absorica and Absorica LD label also lists sexual dysfunction that may continue after discontinuation; the Accutane label does not use that wording [1][2]. Depression is described differently: some patients reported it cleared on stopping and returned when treatment restarted [1][2].
Can isotretinoin cause inflammatory bowel disease months later?
Inflammatory bowel disease is a labeled adverse reaction, and the Absorica label says treatment should be discontinued for abdominal pain, rectal bleeding, or severe diarrhea [1]. The labels do not establish that it first appears months after stopping isotretinoin [1][2].
Is hair loss from isotretinoin permanent?
The labels list alopecia, which in some cases persisted [1][2].
Does isotretinoin cause depression after you stop taking it?
The labels list depression as a risk during treatment and note that some patients reported it subsided with discontinuation and recurred with reinstitution of treatment [1][2].
What post-treatment intervals do the labels set?
The Absorica label says patients should not donate blood for 1 month after the last dose and that breastfeeding is not recommended for at least 8 days; waxing and skin resurfacing are to be avoided for at least 6 months; a second course waits at least 8 weeks to 2 months [1][2].
References
- U.S. National Library of Medicine, DailyMed. Absorica and Absorica LD isotretinoin capsules (Sun Pharma) prescribing information. Absorica and Absorica LD isotretinoin capsules (Sun Pharma) label
- U.S. National Library of Medicine, DailyMed. Accutane-format isotretinoin label (older non-PLR format) prescribing information. Accutane-format isotretinoin label (older non-PLR format) label